A search for genes involved in the inactivation and degradation of enzymes in sporulating Bacills subtilis led to identification of the B. subtilis deg4 gene, whose product stimulates degradation of B. subdis glutamine phosphoribosylpyrophosphate amidotransferase in Escherichia cold cells. degA encodes a 36.7-kDa protein that has sequence similarity to several E. coli and B. subtils regulatory proteins of the LacI class. B. subtilis deg4::cat insertional inactivation mutants had no detectable defect in the inactivation or degradation of phosphoribosylpyrophosphate amidotransferase in glucose-or lysine-starved B. subtilis cells, however. We suggest that degA encodes either a novel protease or, more likely, a gene that stimulates production of such a protease.
Previous work from this laboratory has demonstrated that several biosynthetic enzymes are specifically targeted for inactivation and degradation during early stages of sporulation in nutrient-starved Bacillus subtilis cells. These include two enzymes of nucleotide biosynthesis-glutamine phosphoribosylpyrophosphate (PRPP) amidotransferase, the product of purF (10, 19, 24) , and aspartate transcarbamylase, the pyrB product (2, 17, 21)-and an amino acid biosynthetic enzyme, aspartokinase II (11) . Degradation of these enzymes requires metabolic energy and generally involves the stringent response (29) . The biochemical mechanisms responsible for the selection and degradation of these enzymes are obscure. In particular, proteases involved in their degradation have not been identified. In this study, we have applied a novel approach to the broad question of specific protein degradation in B. subtilis during sporulation.
We have devised an experimental system in which B. subtilis target enzymes serve as substrates in Escherichia coli for cloned B. subtilis activities.
Cloning of activities that inactivate and/or degrade B. subtlis PRPP amidotransferase. The B. subtilis purF gene (18, 19) , expressed from the Serratia marcescens trp promoter (18, 23) , was recloned in pGB2 (Spcr), yielding plasmid pCB101, a low-copy-number pSC101 derivative (5, 6 ).
E. coli EB44 (purFi pyrB59 recA56 hsdR4; strain constructed in this laboratory) containing pCB101 was complemented for its purine auxotrophy by the B. subtilispurF gene and was used as a tester strain to select for activities encoded by B. subtilis genes that could convert the strain to purine auxotrophy. A B. subtilis chromosomal library consisting of fragments from a partial Sau3A digestion cloned into pUC13 (Ampr) was introduced into strain EB44/ pCB101, selecting for resistance to spectinomycin and ampicillin. The transformants (5,650 colonies) were screened by replica plating onto minimal medium containing antibiotics and 50 ,g (each) of adenosine and guanosine per ml or * Corresponding author. Phenotype of strains carrying pCB301 (deg4). During early exponential phase, the growth of strain EB44/pCB101/ pCB301 in the presence of purines was very similar to that of the control strain, EB44/pCB101/pUC13, but became slower than the growth of the control strain during late exponential growth ( Fig. 1 ). To determine whether pCB301 could suppress expression of another B. subtilis gene, plasmid pCB301 was introduced into strain EB44/pCB201, a strain carrying a pGB2-derived plasmid bearing the B. subtilis pyrB gene, the structural gene for aspartate transcarbamylase (17) . The pCB301 plasmid did not cause a Pyr-phenotype in EB44/ pCB201. pCB301 was also introduced into E. coli JM83, JM105, and MM294A. These strains did not become Pur-, nor did they develop any other auxotrophy. PRPP amidotransferase activity and immunochemically cross-reactive material were measured in cultures of strains EB44/pCB101/pCB301 and EB44/pCB101/pUC13 after induction with indoleacrylate ( Fig. 1) . PRPP amidotransferase activity was lost from both strains, after further synthesis was blocked, slightly more slowly for strain EB44/pCB101/ pCB301 than for the control strain. Immunoprecipitable cross-reactive material was also lost from strain EB44/ pCB101/pCB301, but at a lower rate than was activity, whereas the PRPP amidotransferase cross-reactive material was stable in the control strain for at least 6 h. Thus, the pCB301 plasmid appears to carry a gene (or genes) that accelerates the degradation of PRPP amidotransferase protein. On the other hand, both strains showed a similar, slow loss of aspartate transcarbamylase activity during glucose starvation (data not shown).
Extracts of E. coli strains carrying pCB301 and the control plasmid pUC13 were assayed for degradation of purified 4C-labeled (15, 32) Fig. 2A) (21, 24) , the similarity of the DegA and CcpA sequences is intriguing. No significant sequence similarities to proteins of known function were found in the protein data base for the two potential partial open reading frames that flank degA (Fig. 3) .
Overproduction of the degA-encoded protein (DegA) in E.
coli. Overexpression of degA by induction of the lac promoter was obtained in E. coli JM105 bearing the pCB303 plasmid. Amino-terminal sequencing of the protein separated on sodium dodecyl sulfate gels and blotted onto an Immobilon filter (1, 20, 34) identified exactly the first 20 amino acids predicted from the DNA sequence of the major degA open reading frame. The N-terminal methionine was not removed from the DegA protein.
Insertional inactivation of degA in the B. subtilis chromosome. The degA gene in plasmid pCB303 was disrupted by deletion of a 410-bp HincII fragment between bp 769 and bp 1179 in the coding region and insertion of a cat gene from pHW9 (14) , creating pCB308 (Fig. 2B) . pCB308 was incapable of conferring the Pur-phenotype in EB44/pCB101. pCB308 is not able to replicate in B. subtilis because it has only a ColEl origin of replication. However, the cat gene expresses drug resistance in gram-positive hosts. pCB308 was linearized with AvaIl, which cuts in the pUC19 vector outside degA and the cat gene. Transformation of B. subtilis BR16 with this linear DNA led to double-crossover events, in which the chromosomal allele of degA was replaced by the deletion-insertion mutation. Verification of the double-crossover event in the mutant strain, BR16 1-1, was obtained from Southern hybridization experiments (28) using radiolabeled pCB303 as the probe (data not shown).
Because the amino-terminal region of degA is intact in pCB308, a second plasmid with a deletion in degA was constructed. pCB308 was digested with HindIII and SacIl, which deleted a 781-bp fragment that included the amino terminus of degA, the helix-turn-helix region, start codon, and ribosome binding site, as well as the entire 5' portion of the B. subtilis insert (except for 6 bp which lie between the HincII and SacII sites) (Fig. 2B) . DNA homology for recombination was obtained by adding a 640-bp HindIII-SstII fragment from pCB301. This plasmid, called pCB312, conferred a DegA-Cmr phenotype in EB44/pCB101 (Fig. 2B) . pCB312 was linearized with AvaII and introduced into B. subtilis BR16. The resulting mutant strain of B. subtilis was named EB101. Southern hybridization verified that EB101 resulted from a double-crossover insertion into the chromosome with a single copy of degA inactivated by the cat insert.
The degA::cat locus was mapped (7, 30) The growth of strains BR16, BR16 1-1, and EB101 was similar in liquid cultures and on plates. The half-life of PRPP amidotransferase activity was 120 min after glucose starvation and 27 min after lysine starvation for both mutant strains and for their parent (not shown). Loss of PRPP amidotransferase cross-reactive material, as detected by immunoprecipitation or immunoblots, paralleled the loss of PRPP amidotransferase activity. Both degA inactivation mutations were also introduced into B. subtilis protease-deficient strain DB104 (apr npr) (16) by using purified chromosomal DNA isolated from EB101 and selecting for Cmr. No difference in PRPP amidotransferase inactivation or degradation was detected between the mutants derived from strain BR16 and the mutants derived from strain DB104. Thus, insertional inactivation of degA had no effect on the rate of PRPP amidotransferase inactivation or degradation in vivo under the conditions we have examined. Furthermore, expression of degA in B. subtilis BR16 from an induced spac promoter on a multicopy plasmid desired from pSI-1 (33) did not convert the cells to purine auxotrophs, indicating that PRPP amidotransferase was not fully inactivated.
A novel approach to cloning B. subtilis genes involved in the inactivation or degradation of specific enzymes. The gene cloned in the present study, degA, was specific for B. subtilis PRPP amidotransferase in its effects. It did not convert an E. coli purF+ strain to purine auxotrophy, and it did not convert strain EB44/pCB201, which was dependent on cloned B. subtilis pyrB for growth, to pyrimidine auxotrophy. However, other clones of B. subtilis chromosomal DNA which do confer pyrimidine auxotrophy on strain EB44/pCB201, i.e., appear to act by inactivation of B.
subtilis aspartate transcarbamylase, have been isolated (unpublished results). Others that convert both EB44/pCB201 to pyrimidine auxotrophy and EB44/pCB101 to purine auxotrophy have been isolated. Most of these plasmids were quite unstable, but their further characterization is clearly of great interest.
Properties of the deg4-encoded product. B. subtilis degA encodes a protein that directly or indirectly accelerates the degradation of B. subtilis PRPP amidotransferase in an E. coli host. Interestingly, the rate of PRPP amidotransferase inactivation was only slightly faster in the degA-bearing strain (Fig. 1A) . Previous studies support the conclusion that the rate-limiting step in inactivation of B. subtilis PRPP amidotransferase is the reaction of an essential iron-sulfur cluster in the enzyme with 02, which is not catalyzed by an enzyme (10) . If that view is correct, accelerated degradation of the amidotransferase protein would be expected to have little or no effect on the rate of the inactivation step. How then is it possible that the degA-bearing clones of strain EB48 are purine auxotrophs? We cannot provide a definitive answer. One possibility is that the inactivation of PRPP amidotransferase is reversible in E. coli in vivo, so that in the absence of degradation a portion of the enzyme survives and regains activity. The level of B. subtilis purF expression is expected to be much lower in cells grown on plates without inducer (indoleacrylate). Thus, even a modest kinetic coupling between the rate of PRPP amidotransferase inactivation and its degradation might be accentuated on plates and give rise to purine auxotrophy.
Our results suggest that degA either encodes a protease with appreciable selectivity for B. subtilis PRPP amidotransferase or a protein that promotes formation or activation of such a protease in E. coli. The deduced amino acid sequence of DegA is significantly related to several E. coli and B. subtilis regulatory proteins. The regions of similarity include a helix-turn-helix motif found in the DNA-binding domains of these proteins, which suggests that DegA may be a regulatory protein that controls the expression of one or more protease genes. It is also possible that DegA acts in a less specific manner, that is, it is recognized as an abnormal protein and induces heat shock or other inducible degradative systems.
The observation that two B. subtilis strains in which the degA gene was insertionally inactivated degraded PRPP amidotransferase normally during starvation for glucose or amino acids raises the possibility that degA is not a component of the normal pathway for the degradation of this enzyme in B. subtilis. Failure of plasmid-borne degA to cause a Pur-phenotype (indicating inactivation-degradation of PRPP amidotransferase) after induction in B. subtilis cells also raises questions about the specific physiological function of the gene. However, it is also possible that degradation is catalyzed by multiple parallel pathways, so that disruption of one of the pathways fails to block degradation. If this is the case, it will be necessary to seek other genes of the deg class and to construct strains with multiple mutations to evaluate the physiological effects of disrupting them. Such an approach has been necessary to establish the physiological importance of multiple peptidases in E. coli (22) . The possibility exists that the relative levels of DegA and PRPP amidotransferase are critical for the Pur-phenotype. The gene could also fail to act in B. subtilis because other components of the system, not active in the E. coli tester strain, regulate DegA function when the protein is overexpressed.
Nucleotide sequence accession number. The DNA sequence for the B. subtilis degA gene and its flanking sequences has been deposited in the GenBank data base under accession number L08822.
